1. Broadly neutralizing human antibodies against Omicron subvariants of SARS-CoV-2
- Author
-
Hsiao-Ling Chiang, Kang-Hao Liang, Ruei-Min Lu, Ting-Wen Kuo, Yi‑Ling Lin, and Han-Chung Wu
- Subjects
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,Omicron ,XBB.1.5 ,BQ.1.1 ,Single B cell cloning ,Neutralizing human antibody ,Medicine - Abstract
Abstract Background The COVID-19 pandemic continues to pose a significant worldwide threat to human health, as emerging SARS-CoV-2 Omicron variants exhibit resistance to therapeutic antibodies and the ability to evade vaccination-induced antibodies. Here, we aimed to identify human antibodies (hAbs) from convalescent patients that are potent and broadly neutralizing toward Omicron sublineages. Methods Using a single B-cell cloning approach, we isolated BA.5 specific human antibodies. We further examined the neutralizing activities of the most promising neutralizing hAbs toward different variants of concern (VOCs) with pseudotyped virus. Results Sixteen hAbs showed strong neutralizing activities against Omicron BA.5 with low IC50 values (IC50
- Published
- 2023
- Full Text
- View/download PDF